Novel approach to generate reliable breast tumor models may pave way for better immunotherapies
The discrepancy between preclinical advances in breast cancer immunotherapy and poor patient outcomes is rooted in the limitations of current breast cancer models. These models often fail to mimic complex interactions between cancer cells and key immune cells present in the tumor microenvironment.
Source: news-medical.net